ACCR: AI 评分 61/100 — AI 分析 (4月 2026)

概要：

ACCR是做什么的？

ACCR的投资论点是什么？

ACCR在哪个行业运营？

ACCR有哪些增长机遇？

• Expansion of Clones By Drones and Clones by Cars: The company can increase its market share by expanding the distribution network for its marijuana clone products. This involves targeting new geographic markets and establishing partnerships with dispensaries and growers. The legal cannabis market is projected to reach $42.9 billion by 2027, providing a substantial growth opportunity for clone providers. Timeline: Ongoing.
• Increased Adoption of Calming Pet Products: The market for pet calming products is growing as pet owners seek natural remedies for anxiety and stress in animals. Access-Power & Co., Inc. can capitalize on this trend by expanding its mycbdpets.com platform and introducing new product offerings. The pet CBD market is expected to reach $2.5 billion by 2028. Timeline: Ongoing.
• Strategic Partnerships: Forming strategic alliances with established players in the cannabis industry can provide Access-Power & Co., Inc. with access to new markets, technologies, and resources. This includes partnerships with cultivation facilities, research institutions, and distribution networks. Timeline: 12-24 months.
• Product Diversification: Expanding the product line beyond clones and calming pet products can reduce the company's reliance on specific market segments. This includes developing new cannabis-based products, such as edibles, topicals, and concentrates. Timeline: 18-36 months.
• Online Marketing and E-commerce: Investing in online marketing and e-commerce capabilities can enhance the company's brand visibility and reach a wider customer base. This includes optimizing the mycbdpets.com platform for online sales and implementing targeted advertising campaigns. The e-commerce cannabis market is projected to grow significantly in the coming years. Timeline: Ongoing.

• Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
• P/E ratio of -3.08 reflects current unprofitability, requiring careful monitoring of future earnings potential.
• Gross margin of 59.0% suggests a strong potential for profitability if sales volume increases and operational costs are managed effectively.
• Beta of 3.05 indicates high volatility compared to the market, making it a higher-risk investment.
• The company operates with only 1 employee, highlighting its small scale and potential operational constraints.

ACCR提供哪些产品和服务？

• Manufactures medical marijuana clones.
• Distributes clones under the Clones By Drones brand.
• Distributes clones under the Clones By Cars brand.
• Offers calming pet products through mycbdpets.com.
• Operates in the cannabis industry.
• Focuses on niche markets within the cannabis sector.

ACCR如何赚钱？

• Manufacturing and selling medical marijuana clones to growers and dispensaries.
• Selling calming pet products directly to consumers through an online platform.
• Generating revenue through product sales.

• Medical marijuana growers.
• Medical marijuana dispensaries.
• Pet owners seeking calming products.

• Brand recognition within the niche market of marijuana clones.
• Proprietary cultivation techniques for producing high-quality clones.
• Established online platform for selling calming pet products.

什么因素可能推动ACCR股价上涨？

• Ongoing: Expansion of the Clones By Drones and Clones by Cars brands through increased distribution and marketing efforts.
• Ongoing: Growing demand for calming pet products, driving increased sales through the mycbdpets.com platform.
• Upcoming: Potential regulatory changes in the cannabis industry that could create new market opportunities.
• Upcoming: Strategic partnerships with established cannabis companies to expand market reach and access new technologies.
• Ongoing: Development of new cannabis-based products to diversify the company's product line.

ACCR的主要风险是什么？

• Potential: Regulatory changes in the cannabis industry that could restrict or prohibit the company's operations.
• Ongoing: Intense competition from larger cannabis companies with greater financial resources.
• Potential: Fluctuations in the price of cannabis, impacting the company's profitability.
• Ongoing: Limited financial resources and small scale of operations, hindering the company's ability to compete effectively.
• Potential: Low liquidity and trading volume of the stock, making it difficult to exit positions.

ACCR的核心优势是什么？

• Niche market focus on medical marijuana clones.
• Established brand names (Clones By Drones, Clones By Cars).
• Online platform for pet calming products (mycbdpets.com).

ACCR的劣势是什么？

• Small scale of operations (1 employee).
• Limited financial resources (market cap of $0.00B).
• Negative profitability (negative P/E and profit margin).

ACCR有哪些机遇？

• Expansion into new geographic markets.
• Increased adoption of calming pet products.
• Strategic partnerships with established cannabis companies.

ACCR面临哪些威胁？

• Regulatory changes in the cannabis industry.
• Increasing competition from larger cannabis companies.
• Fluctuations in the price of cannabis.

ACCR的竞争对手是谁？

• American Premium Water Corporation — Focuses on CBD-infused products. — (ABWN)
• Body and Mind Inc. — Operates cannabis dispensaries and cultivation facilities. — (BOTY)
• CMG Holdings Group, Inc. — Involved in the cannabis and hemp industries. — (CMGO)
• Hyundai ImageQuest Co., Ltd. — Technology company, indirect competitor through potential technology applications in cannabis. — (HYWI)
• iLids, Inc. — Focuses on eye care products, unrelated to Access-Power's core business. — (ILIM)

Key Metrics

• Volume: 0
• MoonshotScore: 61/100

Company Profile

• CEO: Patrick J. Jensen
• Headquarters: Grand Haven, US
• Employees: 1
• Founded: 1997

AI Insight

• OTC Tier: OTC Other
• Disclosure Status: Unknown